Placenta-derived mesenchymal stem cells (p-MSCs) have been found to significantly enhance renal function and reduce podocyte injury in rats with DKD by regulating the sirtuin 1 (SIRT1)/FoxO1 pathway and promoting autophagy in the podocytes [168]. The gene discussed is FOXO1; the disease is diabetic kidney disease.